Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

The relationship between antibody titers and incident SARS-CoV-2 infection among recipients of a primary vaccine series

Researchers evaluated whether serologic testing could help estimate the risk of SARS-CoV-2 infection in vaccinated individuals who had not received a booster dose.

17 Feb 2023

Discrepancies in perceived and documented long COVID data

Researchers longitudinally assessed the long COVID evidence gap by comparing self-documented data and clinical codes of long COVID with the electronic health records of the participants.

17 Feb 2023

The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals

Researchers determined the prevalence of antibodies against the SARS-CoV-2 spike glycoprotein following three or more doses of COVID-19 vaccines among immunocompromised individuals.

17 Feb 2023

COVID-19 virus can be detected in tears collected by swabbing, research finds

Research led by scientists at the University of São Paulo (USP) in Brazil has found that the coronavirus that causes COVID-19 can be detected in tears collected by swabbing.

16 Feb 2023

In the wake of COVID restrictions being lifted, kids' screen time has remained high

In a recent study published in the journal JAMA Network Open, researchers investigated whether the coronavirus disease 2019 (COVID-19) pandemic-related social changes such as attending classes from home and social distancing measures resulted in a sustained increase in children's screen time.

16 Feb 2023

Research looks to determine prevalence of organ impairment in long-COVID patients

In a recent study published in the Journal of the Royal Society of Medicine, researchers assessed the association of long coronavirus disease (COVID) with multiple organ dysfunction.

16 Feb 2023

Omicron has higher risk of in-hospital mortality compared to influenza

In a recent study published in the journal JAMA Network Open, researchers compared the hospital outcomes of patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant with those of influenza patients in Switzerland, assess the current disease burden due to coronavirus disease 2019 (COVID-19).

16 Feb 2023

Long-COVID associated with a greater likelihood of unemployment

In a recent study published in the journal JAMA Network Open, researchers assessed the unemployment rates among individuals who developed post–coronavirus disease 2019 (COVID-19) condition (PCC) or long COVID after an acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to determine the functional and neurocognitive impairment levels associated with long COVID.

16 Feb 2023

Chest CT findings and pulmonary function in COVID-19 patients

In a recent study published in the Radiology journal, researchers performed the longitudinal evaluation of chest computerized tomography (CT) findings along with pulmonary function in coronavirus disease 2019 (COVID-19) patients.

16 Feb 2023

After recovering from mild to moderate COVID-19, asthma control deteriorates

In a recent study published in the Respiratory Research journal, researchers in Hong Kong assessed the deterioration of asthma control in patients recovering from mild to moderate coronavirus disease 2019 (COVID-19).

16 Feb 2023

Adults who received COVID-19 vaccines reported short-term reductions in depressive and anxiety symptoms

A recent study on Swedish adults explored the prevalence of mental health symptoms before and after immunization with coronavirus disease 2019 (COVID-19) vaccines. The study is published in the journal PLOS ONE.

16 Feb 2023

Study finds potential racial and ethnic disparities in long COVID symptoms

Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

16 Feb 2023

Genetic features of the immune system linked to a person's ability to resist new COVID-19 variants

An international team including researchers from the HSE University Faculty of Biology and Biotechnology has found a link between certain genetic features of the immune system and one's ability to effectively resist new waves of COVID-19.

16 Feb 2023

Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes

Researchers evaluated the effectiveness of nirmatrelvir–ritonavir in preventing coronavirus disease 2019 (COVID-19) severity outcomes during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant predominance.

16 Feb 2023

Cohort study examines the incidence of SARS-CoV-2 rebound in patients on oral antivirals

Researchers performed a retrospective population-wide cohort study using anonymized data in Hong Kong, China, between February 26 and July 3, 2022.

16 Feb 2023

Death of a zoo hippopotamus underscores the species’ susceptibility to SARS-CoV-2

A recent study investigated the death of a hippopotamus at a zoo in Hanoi, Vietnam.

16 Feb 2023

Smoking and vaping may put healthy young people at risk of severe COVID

The levels of some ADAM17 targets were elevated in the plasma of tobacco cigarette smokers as compared to non-smokers.

15 Feb 2023

Post-COVID-19 CT scans show lung abnormalities persist two years later

In a recent study published in the journal Radiology, researchers longitudinally assessed changes in chest computed tomography (CT) abnormities and lung function among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Feb 2023

COVID-19 is associated with higher diabetes and hypertension risk

In a recent study published in the journal JAMA Network Open, researchers determined new-onset diabetes, hypertension, and hyperlipidemia, all cardiometabolic disorders in adult coronavirus disease 2019 (COVID-19) patients under treatment in California, United States of America (USA) between March 2020 and June 2022.

15 Feb 2023

Nirmatrelvir-ritonavir therapy effective against Omicron BA.4/BA.5

Researchers examine non-hospitalized adult patients with COVID-19 treated with nirmatrelvir-ritonavir.

15 Feb 2023

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

The relationship between antibody titers and incident SARS-CoV-2 infection among recipients of a primary vaccine series

Discrepancies in perceived and documented long COVID data

The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals

COVID-19 virus can be detected in tears collected by swabbing, research finds

In the wake of COVID restrictions being lifted, kids' screen time has remained high

Research looks to determine prevalence of organ impairment in long-COVID patients

Omicron has higher risk of in-hospital mortality compared to influenza

Long-COVID associated with a greater likelihood of unemployment

Chest CT findings and pulmonary function in COVID-19 patients

After recovering from mild to moderate COVID-19, asthma control deteriorates

Adults who received COVID-19 vaccines reported short-term reductions in depressive and anxiety symptoms

Study finds potential racial and ethnic disparities in long COVID symptoms

Genetic features of the immune system linked to a person's ability to resist new COVID-19 variants

Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes

Cohort study examines the incidence of SARS-CoV-2 rebound in patients on oral antivirals

Death of a zoo hippopotamus underscores the species’ susceptibility to SARS-CoV-2

Smoking and vaping may put healthy young people at risk of severe COVID

Post-COVID-19 CT scans show lung abnormalities persist two years later

COVID-19 is associated with higher diabetes and hypertension risk

Nirmatrelvir-ritonavir therapy effective against Omicron BA.4/BA.5

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in